Cargando…
Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
Antibodies against severe acute respiratory syndrome coronavirus-2 (Anti-SARS-COV-2) can be detected in patients with COVID-19 in 7 to 10 days post onset of symptoms (POS). However, there is no firm evidence of the long-term persistence of these antibodies in recovered COVID-19 patients. Therefore,...
Autores principales: | Yousefi, Zahra, Taheri, Niloofar, Dargahi, Motahareh, Chaman, Reza, Binesh, Ehsan, Emamian, Mohammad Hassan, Jafari, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853199/ https://www.ncbi.nlm.nih.gov/pubmed/35150319 http://dx.doi.org/10.1007/s00284-022-02800-0 |
Ejemplares similares
-
Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021) -
SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021) -
Advances in immunotherapy for COVID-19: A comprehensive review
por: Masoomikarimi, Masoomeh, et al.
Publicado: (2021) -
Persistence of IgG COVID-19 antibodies: A longitudinal analysis
por: Carvalho, Álvaro, et al.
Publicado: (2023) -
Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)